RNA aptamers interfering with nucleophosmin oligomerization induce apoptosis of cancer cells

Y Jian1, Z Gao, J Sun

  • 1Key Laboratory of Molecular and Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.

Oncogene
|September 8, 2009
PubMed

Insights

Researchers developed RNA aptamers targeting Nucleophosmin (NPM), a protein overexpressed in cancers. These aptamers disrupt NPM

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • Nucleophosmin (NPM) is a key protein regulating cell proliferation and apoptosis.
  • NPM negatively controls p53 levels and is often overexpressed in various cancers.
  • Identifying molecules that inhibit NPM is crucial for cancer therapy development.

Purpose of the Study:

  • To discover novel RNA aptamers with high affinity and specificity for NPM.
  • To investigate the functional impact of NPM inhibition on cancer cells.
  • To explore the therapeutic potential of NPM-targeting aptamers.

Main Methods:

  • Systematic Evolution of Ligands by Exponential Enrichment (SELEX) for aptamer selection.
  • In vitro and in vivo assays to assess aptamer binding and effects.
  • Analysis of protein localization (NPM, p14ARF) and p53 levels.
  • Assessment of cancer cell apoptosis induction and susceptibility.

Main Results:

  • Selected RNA aptamers bind to NPM's central acidic region and inhibit its oligomerization.
  • NPM aptamers cause mislocalization of NPM and p14ARF from the nucleolus to the nucleoplasm.
  • NPM aptamer expression leads to p53 upregulation and increased cancer cell apoptosis.
  • Cancer cells with NPM aptamers show enhanced susceptibility to DNA-damaging agents.

Conclusions:

  • Interfering with NPM oligomerization effectively inhibits its oncogenic functions.
  • NPM-specific aptamers demonstrate potential as a novel therapeutic strategy for cancer.
  • Targeting NPM oligomerization offers a promising avenue for developing new anticancer drugs.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...